Radiation-Induced Disorder

2

Review clinical trials related to Radiation-Induced Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

Study aims to determine if functional lung avoidance based on perfusion single photon emission (SPECT)/CT scan, improves toxicity outcomes for patients with advanced lung cancer undergoing chemo-radiotherapy. Functional avoidance implies a dose plan that takes functional distribution in the lung into account, and avoids highly functional lung volumes sparing them from radiation.

Participants needed: 90
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of AarhusUpdated: Feb 24, 2026Locations: 2
Eligibility criteria

histologically verified lung cancer (small-cell and non-small cell lung cancer) [+6]

concurrent immunotherapy [+2]

Status: Recruiting

Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment

Gynecological cancers, including those affecting the ovaries, uterus, and cervix, represent a significant health burden for women. While survival rates have improved, many women experience chronic pelvic pain secondary to cancer treatment, especially radiotherapy and chemotherapy. This treatment-induced pelvic pain can be of difficult management and significantly affects patients' quality of life. In our experience, ozone therapy has emerged as a promising complementary treatment for pain relief in patients with chronic diseases, including side effects of cancer treatment. However, the genetic and epigenetic mechanisms influencing its effectiveness have not yet been thoroughly studied. The aim of this prospective study is to analyze how ozone therapy modulates the expression of certain genes and its impact on epigenetic clocks, which could help predict pain response.

Participants needed: 40
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Bernardino Clavo, MD, PhDUpdated: Feb 12, 2025Locations: 1
Eligibility criteria

Adult women (>=18 years old) with gynecological tumors treated with radiotherapy... [+5]

Age < 18 years old. [+5]